Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dihydrochloride
- Catalog No. :
- ACLRJK205
- CAS No. :
- 1009119-65-6
- Molecular Formula :
- C40H52Cl2N8O6
- Molecular Weight :
- 811.81
IUPAC Name:methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dihydrochloride
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$151.00Login to see priceIn stockInquiry
25g98%$581.00Login to see priceIn stockInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dihydrochloride |
|---|---|
| IUPAC Name | methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dihydrochloride |
| Molecular Formula | C40H52Cl2N8O6 |
| Molecular Weight | 811.81 |
| SMILES | O=C([C@@H](NC(OC)=O)C(C)C)N1[C@@H](CCC1)C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C([C@@H](NC(OC)=O)C(C)C)=O.Cl.Cl |
| InChI Key | BVZLLUDATICXCI-JMSCDMLISA-N |
| Synonym | Daclatasvir dihydrochloride | 1009119-65-6 | daclatasvir hydrochloride | BMS-790052 dihydrochloride | Daclatasvir 2HCl | BMS 790052-05 | BMS-790052-05 | Daclatasvir (dihydrochloride) | Daklinza | CHEBI:83800 | 50ZO25C11D | Daclatasvir dihydrochloride (USAN) | Daclatasvir dihydro |
| CAS No. | 1009119-65-6 |
| PubChem CID | 25154713 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H317
- Precautionary Statement(s)
- P280

